Randomized Trialhigh evidence
On-chip 3D potency assay for prediction of clinical outcomes for cell therapy candidates for osteoarthritis.
Nature communications·May 27, 2025·PMID 40425577
Why it mattersCurrent cell therapy potency assays poorly predict clinical outcomes, hindering translation. This on-chip 3D assay offers a more clinically predictive tool, potentially enabling better patient selection and product characterization for regenerative pain treatments.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled